Testicular cancer: biology and biomarkers - PubMed

Affiliations

• PMID: 24487784
• DOI: 10.1007/s00428-013-1522-1

Review

Testicular cancer: biology and biomarkers

Leendert H J Looijenga et al. Virchows Arch. 2014 Mar.

Abstract

The term "human germ cell tumors" (GCTs) refers to a heterogeneous group of neoplasms, all with a defined histological appearance. They have specific epidemiological characteristics, clinical behavior, and pathogenesis. Histologically, GCTs contain various tissue elements, which are homologs of normal embryogenesis. We have proposed a subclassification of GCTs in five subtypes, three of which preferentially occur in the testis. These include teratomas and yolk sac tumors of neonates and infants (type I), seminomas and nonseminomas of (predominantly) adolescents and adults (type II), and spermatocytic seminomas of the elderly (type III). Both spontaneous and induced animal models have been reported, of which the relevance for human GCTs is still to be clarified. Multidisciplinary studies have recently shed new light on the (earliest steps in the) pathogenesis of GCTs, mainly in regard of malignant type II GCTs (germ cell cancer (GCC)). This review discusses novel understanding of the pathogenesis of (mainly) GCC, focusing on identification of informative diagnostic markers suitable for application in a clinical setting. These include OCT3/4, SOX9/FOXL2, SOX17/SOX2, as well as embryonic microRNAs. These markers have been identified through studies on normal embryogenesis, specifically related to the gonads, including the germ cell lineage. Their strengths and limitations are discussed as well as the expected future approach to identify the group of individuals at highest risk for development of a GCC. The latter would allow screening of defined populations, early diagnosis, optimal follow-up, and potentially early treatment, preventing long-term side effects of systemic treatment.

Similar articles

• Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.

  Looijenga LH, Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW. Looijenga LH, et al. Ann N Y Acad Sci. 2007 Dec;1120:187-214. doi: 10.1196/annals.1411.000. Epub 2007 Oct 2. Ann N Y Acad Sci. 2007. PMID: 17911410 Review.

• Pathobiology of testicular germ cell tumors: views and news.

  Looijenga LH, Oosterhuis JW. Looijenga LH, et al. Anal Quant Cytol Histol. 2002 Oct;24(5):263-79. Anal Quant Cytol Histol. 2002. PMID: 12408559 Review.

• Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.

  Gillis AJ, Stoop H, Biermann K, van Gurp RJ, Swartzman E, Cribbes S, Ferlinz A, Shannon M, Oosterhuis JW, Looijenga LH. Gillis AJ, et al. Int J Androl. 2011 Aug;34(4 Pt 2):e160-74. doi: 10.1111/j.1365-2605.2011.01148.x. Epub 2011 Jun 2. Int J Androl. 2011. PMID: 21631526

• Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle.

  Gillis AJ, Rijlaarsdam MA, Eini R, Dorssers LC, Biermann K, Murray MJ, Nicholson JC, Coleman N, Dieckmann KP, Belge G, Bullerdiek J, Xu T, Bernard N, Looijenga LH. Gillis AJ, et al. Mol Oncol. 2013 Dec;7(6):1083-92. doi: 10.1016/j.molonc.2013.08.002. Epub 2013 Aug 20. Mol Oncol. 2013. PMID: 24012110 Free PMC article. Clinical Trial.

Cited by

• Identifying functional cancer-specific miRNA-mRNA interactions in testicular germ cell tumor.

  Sedaghat N, Fathy M, Modarressi MH, Shojaie A. Sedaghat N, et al. J Theor Biol. 2016 Sep 7;404:82-96. doi: 10.1016/j.jtbi.2016.05.026. Epub 2016 May 25. J Theor Biol. 2016. PMID: 27235586 Free PMC article.

• Risk for testicular germ cell tumors and spermatogenesis failure in post-pubertal undescended testes.

  Ergül RB, Bayramoğlu Z, Keçeli AM, Dönmez Mİ. Ergül RB, et al. Int Urol Nephrol. 2024 Jul;56(7):2269-2274. doi: 10.1007/s11255-024-03963-4. Epub 2024 Feb 13. Int Urol Nephrol. 2024. PMID: 38349599

• Single-cell multi-omics analysis of human testicular germ cell tumor reveals its molecular features and microenvironment.

  Lu X, Luo Y, Nie X, Zhang B, Wang X, Li R, Liu G, Zhou Q, Liu Z, Fan L, Hotaling JM, Zhang Z, Bo H, Guo J. Lu X, et al. Nat Commun. 2023 Dec 20;14(1):8462. doi: 10.1038/s41467-023-44305-9. Nat Commun. 2023. PMID: 38123589 Free PMC article.

• XIST-Promoter Demethylation as Tissue Biomarker for Testicular Germ Cell Tumors and Spermatogenesis Quality.

  Lobo J, Nunes SP, Gillis AJM, Barros-Silva D, Miranda-Gonçalves V, Berg AVD, Cantante M, Guimarães R, Henrique R, Jerónimo C, Looijenga LHJ. Lobo J, et al. Cancers (Basel). 2019 Sep 17;11(9):1385. doi: 10.3390/cancers11091385. Cancers (Basel). 2019. PMID: 31533343 Free PMC article.

• In Search of TGCT Biomarkers: A Comprehensive In Silico and Histopathological Analysis.

  Raos D, Krasic J, Masic S, Abramovic I, Coric M, Kruslin B, Katusic Bojanac A, Bulic-Jakus F, Jezek D, Ulamec M, Sincic N. Raos D, et al. Dis Markers. 2020 Nov 6;2020:8841880. doi: 10.1155/2020/8841880. eCollection 2020. Dis Markers. 2020. PMID: 33224314 Free PMC article.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program